Public Health

People want to open up the economy, but don’t necessarily want to risk going out themselves.

As Covid-19 continues to disrupt traditional care norms, major pharma products have an unprecedented opportunity to define new market dynamics and demonstrate population health leadership.

Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.

Manufacturers of the 48 launched products since January 2019 are facing a unique challenge in the current Covid-19 market.

Hard-hit Italy and China support reopening.

America weighs the options

This fourth edition sees us bring together our latest research on coronavirus and draws on our surveys, social media monitoring and the analysis of our teams around the world.

Lack of Motivation Is the Top Obstacle to Improving Health

Consumer confidence and poll on economic outlook show doubts about recovery ahead.